The manufacturer of Vanta has taken it off the market and replaced it with a different version costing 7x as much.
The cause of this is one party has a policy of selling out all it's votes to pharma. The some party that is most supported by the older patients most adversely effected by bad pharma behavior.
NPR: Drug company drops its cheaper hormone-blocking drug, keeps pricier one : Shots - Health News.